Estrella Immunopharma, Inc. (ESLA)

NASDAQ: ESLA · IEX Real-Time Price · USD

1.070

+0.050 (4.90%)

At close: Apr 19, 2024, 4:00 PM

1.060

-0.010 (-0.93%)

After-hours: Apr 19, 2024, 6:34 PM EDT

Estrella Immunopharma Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021
Selling, General & Admin	0.66	1.37	0.28
Research & Development	10.45	0	0.46
Other Operating Expenses	0	0.2	0
Operating Expenses	11.11	1.57	0.73
Operating Income	-11.11	-1.57	-0.73
Other Expense / Income	-	-0.65	-
Pretax Income	-11.11	-0.92	-0.73
Income Tax	0	0.08	0
Net Income	-11.11	-1	-0.73
Shares Outstanding (Basic)	1	6	1
Shares Outstanding (Diluted)	1	6	1
Shares Change	-77.96%	476.29%	-
EPS (Basic)	-8.75	-0.22	-733.69
EPS (Diluted)	-8.75	-0.22	-733.69
Free Cash Flow	-1.34	-1.04	-
Free Cash Flow Per Share	-1.05	-0.18	-
EBITDA	-11.11	-0.92	-
EBIT	-11.11	-0.92	-0.73

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).